Ladies and gentlemen, thank you for standing by. The operator provided instructions to participants. Welcome to Avery Dennison's earnings conference call for the first quarter ended April 3, 2021. This call is being recorded and will be available for replay from noon Pacific Time today through midnight Pacific Time, May 1. To access the replay, please dial 800-633-8284 or 1-402-977-9140 for international callers. The conference ID number is 21969419. I'd now like to turn the call over to John Eble, Avery Dennison's Head of Investor Relations. Please go ahead, sir.

Thank you, Pama. Please note that throughout today's discussion, we'll be making references to non-GAAP financial measures. The non-GAAP measures that we use are defined, qualified and reconciled with GAAP on schedules A-4 to A-8 of the financial statements accompanying today's earnings release. We remind you that we'll make certain predictive statements that reflect our current views and estimates about our future performance and financial results. These forward-looking statements are made subject to the safe harbor statement included in today's earnings release. On the call today are Mitch Butier, Chairman, President and Chief Executive Officer; and Greg Lovins, Senior Vice President and Chief Financial Officer. I'll now turn the call over to Mitch.

Thanks, John, and good day, everyone. We are off to a strong start to the year with revenue up 11%, EPS up 45%, both well above expectations, and strong free cash flow. The favorable results were driven by improving and broad-based volume and productivity gains across the portfolio as all 3 of our operating segments delivered strong sales growth and significant margin expansion. We experienced strong demand as many economies emerged from the depths of the recession amidst rising confidence. This, combined with both the structural and temporary productivity initiatives we've implemented, drove a strong quarter. Now while we are pleased with the results, our strong performance comes at a time of continued uncertainty, given the global health crisis and constraints within supply chains. The current environment further reinforces our determination to remain vigilant in protecting the health and well-being of our team and agile to ensure we continue to meet our customers' needs. While the rate of COVID-19 infections declined in a number of countries, including the U.S., and optimism increases as vaccines roll out, much of Continental Europe has been in lockdown, and other countries such as India and Brazil have experienced a significant rise in infection rates. Fortunately, the rate of new cases among the team remains relatively stable. In addition to the effects of the pandemic, natural disasters such as the Texas winter storm and other factors, the microchip shortage being an example, are constricting supply chains even further, affecting our end markets and adding to inflationary pressures. Despite these supply chain constraints, we've been able to deliver record volumes as our team has done a great job of leveraging our global network and scale to ensure we continue to meet customers' needs. Now a quick update by business. Label and Graphic Materials posted strong top line growth for the quarter as demand for consumer packaged goods and e-commerce trends continue to drive strong volume in our Label and Packaging Materials business, while our Graphics and Reflective Solutions business rebounded faster than expected. LGM's margin was strong in the quarter, ahead of expectations actually, as the flow-through from higher volume, including strength in high-value categories, coupled with productivity gains, enabled significant margin expansion. Retail Branding and Information Solutions delivered strong sales growth in the quarter driven by both high-value product categories, particularly RFID and the core apparel business. The strong top line was driven by retailers and brands gearing up for a rebound in demand and, to a lesser extent, easier comps. Enterprise-wide Intelligent Labels sales were up 40% ex currency and up 20% on an organic basis. As expected, the strong growth of our RFID business was primarily driven by apparel, while outside of apparel, we continued to see strong momentum building for new applications. As we outlined in detail at our Investor Day last month, we have a tremendous amount of opportunity in this space, in apparel, food, logistics and more. And as you also heard, our focus is not only to be the world's leading RFID supplier. We are creating a broader Intelligent Labels platform to bridge the physical and digital worlds. As part of this, we are investing in digital identification technologies that enhance the ability to manage and store item level information. To this end, we recently announced 2 digital initiatives: one, the acquisition of a small software start-up, ZippyYum; and the other being the launch of a connected product cloud platform start-up, atma.io. As for the bottom line, RBIS delivered significant margin expansion in the quarter driven by higher volume and productivity initiatives. Given the margin and growth profile of this business, we will continue to ramp up our pace of investments in this segment, particularly in Intelligent Labels, with an accelerated pace throughout the remainder of the year. Turning to Industrial and Healthcare Materials. The segment delivered strong sales growth in the quarter driven by a significant rebound in demand for industrial products, while we continue to make good progress towards achieving the long-term margin target for this business. We continue to invest in this segment, including the acquisition of JDC Solutions, a small manufacturer of specialty tapes for use in a variety of high-value industrial applications, that we closed in March. Now given our strong performance in Q1 and our revised expectations for the rest of the year, we have raised our full year outlook and now anticipate top line growth of 9% to 11% ex currency and earnings per share of $8.40 to $8.80. We are pleased with the continued progress we are making towards the success of all of our stakeholders. Our consistent performance reflects the strength of our markets, our industry-leading positions, the strategic foundations we've laid and our agile and talented team. We remain focused on our 5 key strategies: driving outsized growth in high-value categories, growing profitably in our base businesses, focusing relentlessly on productivity, effectively allocating capital and leading in an environmentally and socially responsible manner. We are confident that the consistent execution of these strategies will enable us to achieve our long-term goals, including consistently delivering GDP-plus growth and top quartile returns. And once again, I want to thank our entire team for their tireless efforts to keep one another safe while continuing to deliver for our customers during this challenging period, bringing a whole new level of agility and dedication to address the unique challenges at hand. Over to you, Greg.

Thanks, Mitch, and hello, everybody. As Mitch said, we delivered a strong start to the year with adjusted earnings per share of $2.40, above our expectations. This roughly $0.75 increase over prior year was driven by strong growth and productivity gains as well as an estimated $0.25 benefit from the combined impact from the calendar shift and prebuys. Sales grew ex currency 11% and 9% on an organic basis driven by strong broad-based demand as well as a modest benefit from easier comps as the pandemic began to impact the results in Q1 of last year. Given the strong revenue, combined with productivity gains, we delivered adjusted EBITDA margin of 16.5% and adjusted operating margin of 13.9%, both up roughly 2 points. And we realized $19 million of net restructuring savings in the quarter, the majority of which represented carryover from projects we had pulled forward into 2020. And we continue to expect roughly $70 million from net restructuring savings this year. As Mitch mentioned, to begin the year, supply chains have remained tight, and input costs have been increasing. As a result, raw material and freight inflation were above our initial expectations, and we have continued to see costs rise as we enter the second quarter. We now expect mid- to high single-digit inflation for the year, with variations by region and product category. As we typically do, we will address this through a combination of both product reengineering and pricing. We've announced price increases in most of our businesses and regions across the world. And given the pricing announcements, some customers accelerated orders into the first quarter, ahead of pricing adjustments. We estimate the prebuy benefit to Q1 was roughly 2 points of revenue growth, and we anticipate this impact will largely come out of Q2. We generated $182 million of free cash flow in the quarter, up substantially compared to last year, primarily driven by improved working capital and higher operating results. Working capital as a percent of sales improved compared to prior year driven by better receivables and inventory turns. And our balance sheet remains strong with a net debt-to-adjusted EBITDA ratio at quarter end of 1.6. Our current leverage position gives us ample capacity to continue executing our disciplined capital allocation strategy, including investing in organic growth and acquisitions while continuing to return cash to shareholders. Last week, we announced that the Board approved a 10% increase to our quarterly dividend rate, following the 7% increase last year. And in the quarter, we paid $52 million in dividends and repurchased roughly 300,000 shares at an aggregate cost of $56 million. And as you know, we increased our pace of inorganic investments last year, and we've continued on that front, deploying $31 million for acquisitions in the first quarter, including JDC Solutions and ZippyYum. Now turning to segment results for the quarter. Label and Graphic Materials sales were up 8.4% excluding currency and 7.6% on an organic basis driven by higher volume. Sales were up roughly 7% organically in Label and Packaging Materials, with strong volume growth in both the high-value product categories and the base business, partially offset by carryover price reductions. Graphics and Reflective sales continued to rebound nicely and were up 9% organically. Looking at the segment's organic sales growth in the quarter by region, North America and Western Europe sales were up low single digits, while emerging markets overall were up mid-teens. The Asia Pacific region grew roughly 20%, led by growth in China and India, although the recent surge in COVID-19 cases in India has heightened uncertainty in the region. And Latin America grew mid-teens, with particular strength in Brazil. LGM's adjusted operating margin increased 150 basis points to 16.3% as the benefits from strong volume, including the benefit of the calendar shift in prebuy, and productivity more than offset higher employee-related costs and the net impact of pricing and raw material costs. Shifting now to Retail Branding and Information Solutions. RBIS sales were up 15% ex currency and 9.3% on an organic basis as growth was strong in both the high-value categories and the base business. The core apparel business was up mid- to high single digits as retailers and brands prepare for the stronger demand, with particular strength in the value and performance channels. And as Mitch indicated, excluding currency, Intelligent Labels sales were up 40% and up 20% on an organic basis. Adjusted operating margin for the segment increased 440 basis points to 12.9% as the benefits from higher volume, lower receivables reserves and productivity more than offset higher employee-related costs and growth investments. Turning to the Industrial and Healthcare Materials segment. Sales increased 18.8% excluding currency and 16.3% on an organic basis, reflecting strong growth in industrial categories, particularly in automotive applications, which more than offset a modest decline in health care. Adjusted operating margin increased 190 basis points to 12.3% as the benefit from higher volume more than offset higher employee-related costs. Now shifting to our outlook for 2021. While there is a continued high level of uncertainty from the pandemic and tight supply chains, we have raised our guidance for adjusted earnings per share to be between $8.40 and $8.80, a $0.75 increase to the midpoint of the range. The increase reflects the strong performance in Q1 as well as an increased outlook for organic sales growth for the balance of the year. We now anticipate 9% to 11% excluding currency sales growth for the full year, above our previous expectation, driven by both the higher volume outlook and the impact of higher prices. We've outlined some of the other key contributing factors to this guidance on Slide 12 of our supplemental presentation materials. In particular, the extra week in the fourth quarter of 2020 will be a headwind of a little more than 1 point to reported sales growth and a roughly $0.15 headwind to EPS to 2021. We estimate Q1 benefited by roughly $0.15 based on the shift in the calendar and anticipate then a roughly $0.30 headwind in Q4. As noted earlier, we estimate the prebuy benefit to Q1 was roughly $0.10 of EPS, which will come out of future quarters, mainly Q2. And the anticipated tailwind from currency translation is roughly 2 points to sales growth and $25 million in operating income for the full year based on recent rates. And the majority of our 2020 temporary cost reductions have come back in at this point. The exception is our belt-tightening costs, travel expenses, for example, which have remained low to start the year, with many of our employees still in lockdown or working from home. And we expect these costs to come back in later through 2021. And finally, given the increased outlook for earnings and working capital productivity, we're now targeting to generate over $675 million of free cash flow this year. So in summary, we delivered another strong quarter in a challenging environment. And we remain on track to deliver on our long-term objectives to achieve GDP-plus growth and top quartile returns on capital, which together drives sustained growth in EVA. And now we'll open up the call for your questions.

The operator provided instructions to participants. Our first question comes from the line of Ghansham Panjabi with Robert W. Baird & Co.

So first off, congrats on 1Q. I guess as we kind of think out ahead, it's still pretty early in the year. Your core sales guidance is now 9% at the midpoint versus 5% previously. Clearly, you have a prebuy in 1Q that may come at the expense of 2Q. You have tough comps in some businesses. And then you have the India and Brazil and other parts of the world virus flare-ups. So I guess in context of that and what you called out in the past in terms of sort of limited visibility on a go-forward basis for your businesses being that they're short-cycle, I guess, what gives you confidence to be able to raise organic sales guidance this early in the year? And also in terms of share gains, are you embedding any sort of future share gains in that?

Thanks, Ghansham. This is Greg. So yes, just maybe to give you a view of how we're thinking about it, when we look at the full year, obviously, in the first quarter, we delivered strong volume growth of about 9%, which added a little more than 2 points to the full year growth rate. We then look at the second and third quarters, which obviously, Q2 last year was the trough in the pandemic for us. And we still had a decline of about 4 points in the third quarter last year as well. So just looking at it, if we can recover the declines that we saw in the businesses most impacted last year by the pandemic in Q2 and Q3, those quarters would add another 4 or 4.5 points of growth to the full year growth rate. So between Q1 and just recovering the declines that we had last year in Q2 and Q3 will get us to about 7 points. And then in addition to that, you'd be looking at an impact from the incremental pricing actions that we've talked about, given the inflationary environment this year. So that's kind of how we've thought about getting to that 8- to 10-point range. The strong growth we had in the first quarter, in addition to recovering the volume declines that we had last year, plus the incremental impact of the pricing.

Okay. And then for my follow-up question, in terms of April, are you seeing the deceleration as it relates to the prebuy that you called out? And then also for the LGM - LPM, I should say, advantage markets from last year, so the packaged food, et cetera, that benefited last year, are you seeing the comparisons change dramatically associated with that? Or you still see elevated demand?

Yes. So overall, April, the trends early on broadly are continuing what we saw in Q1. The impact of the prebuy from the pricing is now we're just starting to see visibility of that to our orders because when we receive the orders, we continue to ship into early April. So we are starting to see as far as order trends that impact a bit from the prebuy. But overall, right now, we're seeing some of the trends continuing into Q2 what we saw in Q1, which further reinforces the guidance that Greg just spoke to. So as far as if you look at it from a market perspective, you asked about share a little bit because we have a little bit of share movement each quarter. We believe share in Q1 was comparable to what we had in North America the last couple of years over the average. And in Europe, we captured some of the share we talked about that we had ceded a year or so ago within the quarter as well. Now all that data is not finalized. That's based on our estimates. So the markets overall for mature regions actually, we believe, moderated in Q1, and that's off of a very tough comp of Q1 of last year, Ghansham. So that's kind of already baked in, a little bit of that tough comps, if you will, from last year as far as the growth within the markets, to what we're seeing. Now conversely, what you're seeing in the emerging markets, as we said, those are up significantly within LGM. So China was pretty soft Q1 of last year and relatively anemic through much of the year. And we saw a big, strong performance here in Q1 and would expect, as that economy continues to rebound, we continue to see good, strong momentum on volumes and so forth within that business.

Our next question comes from the line of Anthony Pettinari with Citigroup Global Markets.

I was wondering if it's possible to say when you'd expect to see price cost balance begin in LGM. I understand that you have a lot of offsets on restructuring savings. But how many quarters will it take you to get caught up with the pricing initiatives? And given a really unprecedented raw material inflation environment, are there any sort of special price increases or special measures that you're undertaking to recover costs?

Yes. Thanks, Anthony. So I think to the last part of your question, of course, at the beginning of the year, particularly in North America - or really at the end of last year, in North America, we started to see the spike in chemicals and films with propylene going up. And we did implement a surcharge there. And I think we've also implemented a surcharge in a couple of other regions as well when we've seen some chemical increases through the first quarter. At the same time, though, as we moved through Q1, we started to see inflationary pressures continue to increase as I talked about a bit earlier. And we expect more of a sequential increase here in the second quarter, probably in the mid-single-digit range from Q1 to Q2, in particular. So from a perspective of managing that or covering that, we always take a two-pronged approach as you've heard us talk about before, looking at material cost reengineering to take cost out as well as increasing pricing to cover the rest of that. So I think overall, we're looking at over a period of time, continuing to be able to cover the inflationary pressures between those two levers. Typically, we do have a quarter or so lag as we've talked about before as well, and we'd expect to see a similar level here this year. We actually in the Q1 year-over-year still had some price down from some of the deflation we had last year.

Okay. That's very helpful. And then just on the chip shortages and any potential impact to your global automotive business in IHM or RFID, we've heard about that impacting readers. Any kind of finer point you can put on the impact of the chip shortage, either in the quarter or maybe the risk for the remainder of the year?

Yes. Well, Anthony, so we're seeing - if you talk about end markets, automotive being a good example, we definitely would be impacted by whatever is happening in the end markets there, and the chip shortage would be impacting that. We talked about our strong growth, and that's including in automotive in Q1, even adjusting for the easier comps. So that's definitely something that should be part of your outlook. It's part of ours, for sure. We think there's also going to be some pent-up demand for automobiles as well. So that's something that we would see as a bit temporary, if you will. More broadly, if you think of RFID, so from our own supply chain standpoint, we feel that we're in a good position to continue to meet our objectives for this year, next year and so forth. Obviously, we've had to jump through a few more hoops, moving things around between various suppliers and so forth. But we feel that we're in a good position overall from that perspective.

Our next question comes from the line of John McNulty with BMO Capital Markets.

Just maybe a follow-up on the raw material side. Just given all of the supply-related issues, the surge in raw material issues, did you have any issues in actually getting material for the quarter? Or do you foresee any for 2Q? And as best you can tell, are you in a similar boat as your competitors? Or did you maybe fare just better just given your scale? I guess how should we think about that?

Well, we absolutely had a lot more hoops to jump through here in the quarter, particularly because of what happened in North America, John, with the Texas winter storm as I called out. So there were areas where we were able to leverage our global scale, sourcing material from various regions as well as just our site overall. But yes, this definitely had an impact in the entire industry, including us, on lead times. So our lead times were a bit longer than the normal two days. There were a few days throughout since that winter storm and continue to be a little bit of elevated levels overall. So yes, it has impacted lead times, not our ability to overall meet customer demands. And as far as on a relative basis, we haven't seen the share data for North America specifically yet. So I can't comment specifically on that, but we feel that we were probably in a better position on a relative basis than the broader market.

Got it. Fair enough. And then maybe you can just speak to on the RFID front, obviously, some really solid volumes. And it sounds like even your excitement level, which has always been pretty high here, it sounds like it may be even higher, and the investment that you're putting into it may be stronger. I guess how should we think about just given all the pilot programs you've been doing, the — what seems to be COVID kind of putting an incremental light on the importance of supply chain management, I guess, how should we think about the ability for at least the next 12 to 18 months, call it, for this business to even accelerate from the high levels that it's at right now?

Well, John, you said our level of excitement is increasing. Maybe we were understated in the past. We've been consistently energized about what this business can do. Yes, as far as with the next 12, 18 months, we've laid out that we expect this business to be able to grow 15% to 20% over the long term. We continue to have that conviction. And as those get built upon ever larger numbers, it has an even greater impact on the overall growth trajectory of the company. So as we said, we have a number of years still ahead of us on just retail apparel adoption. We see huge opportunities in other categories, food and logistics as examples. And we're looking to further build on our RFID capabilities as we build out the Intelligent Label platform. So it's very consistent with what we've been talking about, and we continue to be energized by the opportunities that lie ahead.

Our next question comes from the line of Adam Josephson with KeyBanc Capital Markets.

Congrats on another really good quarter. Greg, the - so you raised your organic sales growth range by 4 points. And if I heard you correctly, I think price - incremental price is about 1 point of that. Please correct me if I'm wrong there. So assuming your volume expectation went up by about 3 points for the year, can you just talk about which regions and end markets particularly surprised you to the upside in the quarter such that you moved the range up by as much as you did?

Yes. So I guess - so I think price, we would expect to be a couple of points this year, given inflation in that kind of mid- to high single-digit range. So again, from a year-over-year perspective, price was down a little in Q1. We'd expect it to be up as we move through the course of the year, given the price increases that were taking effect at the tail end of Q1, in particular, and early here in Q2. So we did raise organic, maybe not quite as much as you indicated. But we certainly raised it just based on the strong growth that we saw coming out of the first quarter across the portfolio really. And then as Mitch already talked about, in April, we're really seeing the rebound and especially in the businesses that were most hardest hit last year. So looking at the year-over-year comps in April isn't as meaningful just given that was really the trough month for a lot of the declines last year in RBIS and Graphics and IHM. But overall, net of the pre-price increase prebuy, we continue to see strong volumes as we entered April. So that's what gives us the confidence to increase the range for the year.

Adam, just to build on that, if you look at our shift in our growth outlook for the year, when we were at Investor Day, we laid out our long-term objectives of 5% plus CAGR through 2025 ex currency. And we said from 2022 and beyond, it'd be 4% plus. And basically, what we're communicating, we couldn't really tell the timing of the recovery and how quick it would come back. We knew by 2022, between this year and next, it will be fully back. And it seems to be coming in a bit quicker than our assumptions were originally. So definitely, things are picking up faster than we had anticipated for the reasons that we've talked about and Greg's referred to. But when you think about long-term perspective, think about it as we weren't sure exactly what the pace and timing of the recovery would be. It seems to be happening a bit quicker than we had previously known.

And I appreciate that, Mitch. And just one follow-up on that. So you had really strong growth in China, which has obviously mostly rid itself of the virus by now. Brazil is almost the exact opposite. And it's one of the worst-hit countries in the world, and yet those were two of your strongest countries in 1Q if I heard you correctly. So what is the common denominator here in terms of the strong growth you're experiencing?

Well, one, there's the general - I mean, the common denominators are e-commerce and focus on consumer packaged goods broadly. Specifically within those, it's a bit different in Brazil. They've had a huge surge in COVID-19, which has a normal migration we've seen elsewhere towards consumer packaged goods. But you also have a lot of stimulus. And so a lot of money in a lot of people's hands, and they are spending it. So that is very different than what we're seeing in China, of course.

We now have a question from the line of Neel Kumar with Morgan Stanley Investment Research.

Great. Can you just give us a sense of what's embedded in your full year guidance in terms of incremental margins for the consolidated company and by segment? Is it still fair to expect a stronger margin step-up from RBIS and IHM just given a higher proportion of value-added categories?

Yes. I guess - so broadly looking at the years, we - as we talked about when we came into 2021 in our last call, looking at high level coming into the year, maintaining or even growing a bit our margins year-over-year, with the biggest part of that growth coming from RBIS, obviously, which was depressed last year, particularly in the second quarter when the trough of the pandemic. So looking at that to recover closer to or maybe better than 2019 levels within RBIS and then continuing to move IHM towards its long-term target. So we expect to continue following that path as we look across the course of the year and continue to drive growth, particularly in those segments. In LGM, we did grow margin 2 points last year. And obviously, with the inflationary pressures here this year, wouldn't look for as much margin growth in LGM as we would see in the other segments in 2021.

And we now have a question from the line of Josh Spector with UBS Securities.

Just on the LGM margins and to kind of follow up on some of the price cost kind of dynamics here. I don't know if you could provide us some context of what you think the exit rate is for LGM this year. Given what you guys stepped up last year over 2019, do you think - is that a sustainable level? Margins have stepped up for you and key peers, but what makes you confident in the margin level of that business? Or what are some of the puts and takes we should think about that?

Yes. Thanks, Josh. So I think we don't give margin targets by business unit for the year. But when we look at where we exited last year, and we talked about our focus on margins for the year, we really expected more growth in RBIS and IHM. In LGM, had already grown a couple of points last year as you said, just looking more to hold that this year. And we've done that, obviously, in the first quarter, but it's not just really about price. It's a bit in the heavy amount of volume growth that we talked about in Q1 as well as a significant amount of productivity. So a lot of the restructuring costs that we talked about came in LGM, particularly in the graphics side of the business, but also with some footprint actions in North America over the last year or so as well. So it's been a combination of driving productivity and continuing to drive that over time, the ongoing every year productivity as well as periodic restructuring type of productivity that's helped drive those margins, in addition to the strong volumes that we've seen recently.

I appreciate that. And just as a follow-up, you talked about the raw material increases and the impact of that near term. How about any cost impact that's kind of baked into your thoughts for the next couple of quarters or maybe using a different formulation that might be more expensive to supply a customer or logistic costs that might be added in this current environment? Is there anything that you would call out as kind of more temporary over the next couple of quarters that's built in?

Well, I think in addition to raw material costs, we have seen cost increases, especially in ocean freight. We've seen cost increases even in things like pallet costs, for instance, as wood costs have gone up a little bit in certain regions. So when we think about inflation, we're looking at it more broadly than just materials. We're looking at all of our input costs, freight and supplies and other things as well. And those are areas where we look to get more productive where we can through productivity actions and then also obviously, increasing price. And we take all those things into account when we think about pricing actions or surcharges on freight and things like that also.

Yes. And Josh, just to build on broader context here. As Greg said, our objective, we've - we're an EVA-driven company, looking from the optimum point between organic growth margins and capital intensity. And we had expanded LGM margins quite a bit going last year. We said our objective was to hold it this year. So that's the overall context. In Q1 specifically, if you recall, we had accelerated a number of restructuring actions. We still have the temporary cost savings as well as the fact that we had the variable flow-through of the prebuy happening. And the margin you see, we remain confident in our ability to hold the margin level based on what we see now, hold the margin level that we had last year. Now that is the total across the regions. A lot of the cost pressures, both raw material as well as the other factors that Greg called out, are disproportionately in North America. So North America is actually having a profitability challenge right now as far as where they are. So the average doesn't necessarily tell the story of what's happening within each region. And I know a lot of us here sitting in the States can see things more of what's happening here. So there's definitely a little bit more of a challenge there that we're working through in both from driving productivity, working with our supply chain partners as well as raising prices right now.

Our next question comes from the line of Rosemarie Morbelli with G. Research.

Well, I recognize it is a small piece of your business, but I am talking about health care. And I know you have great expectations for that business. So can you touch on what is behind the decline? Is it more a question of difficult comps versus a higher demand last year? Or are there other underlying reasons for it?

Yes. So the health care portion of IHM is really two components. One is our medical tape business, and the other would be what we call personal care tapes such as diaper tapes. When we look at medical tapes over the last number of quarters, we've seen, just given a reduction in the number of elective surgeries and things like that, a bit of a reduction that we think we're working through at this point, but a bit of a reduction over the last few quarters of medical tapes as a result of some of those activities being lower than they normally would be. Where we actually saw a decline in this quarter was in diaper tapes. So a year ago, we actually saw an increase there, partially due to some of the surge in stocking up by consumers at the beginning of the pandemic in the U.S. and Europe, in particular. And so we're just seeing a little bit of a comp headwind year-over-year in the diaper tape side in particular.

All right. And then looking at the Smartrac acquisition, have you seen any benefit in terms of expanding your RFID in markets such as auto, food and other markets, which they were bringing some business into?

Yes, absolutely. So Smartrac has been a very fortuitous acquisition for us thus far, given just the continued ramp across all end markets. Specifically, your question around industrial and automotive applications, those actually, as you would expect, given the end markets, declined a bit since the acquisition due to COVID. But as far as the pipeline and the customers we're working with, the number of programs where we've already got ramping up adoption right now, we do continue to see good opportunity there. The key element here was the end market access as well as the broader capabilities. They are very complementary to what we had as a legacy RFID business as well. So overall, the acquisition is meeting and exceeding our expectations on top and bottom line.

Our next question comes from the line of Christopher Kapsch with Loop Capital Markets.

Mitch, in response to a prior question, you mentioned that some of the disruptions and higher raw material costs were more acute and skewed North America. So I'm just wondering if that would imply that your pricing actions were more aggressive also in North America. And really curious if the prebuy, therefore, was more pronounced in North America. I was curious, further, the outsized growth in emerging markets, I was wondering how much they're benefiting from prebuy.

Yes. So we're not - without getting into too much detail, overall, it's not just by region, it's also by category. So films and chemicals is where we tend to see the broad-based level of inflation in Q1. North America definitely was feeling it first, and it's where we announced some of the first price increases in the quarter. But since then, the U.S. kind of led the way, but the rest of the regions have been following as far as the raw material inflation that they're seeing. So when you look at a sequential Q1 to Q2, it's pretty broad-based overall. As far as the prebuy, we're seeing elements of that in a number of regions, but North America is definitely one and then some in the emerging markets as well. Specifically, China is where we believe that we've seen some detectable levels of prebuy.

Okay. And then on the margins in the LGM segment, you mentioned that volumes but also mix contributed and makes sense on the mix with graphics and reflective recovering stronger than you expected and with the outsized growth in emerging markets. So because you've said in the past that emerging markets carry higher margins than the more mature Western markets, so I'm just wondering if any way you could parse out the margin benefit from volume leverage versus mix in terms of the margin improvement in the LGM segment?

Yes. Chris, I don't know if I'd parse out specifically. Clearly, there's a benefit from both, just the strong volumes overall on the Label and Packaging Materials side, and we saw that in the base. But we also saw strong volumes on durable labels and specialty labels, particularly in a handful of regions as well. So there's kind of broad-based strength, not just on graphics and reflective, but also in the durable side of the label business, which typically has a little bit higher variable margins as well. So good mix from strong growth in those areas as well as just really strong volumes on the base portion of LPM as well.

We now have a follow-up question from the line of George Staphos with Bank of America Securities.

My first question was going to focus on RBIS. And kind of the first part of that, in particular, with Intelligent Labels, the 15% to 20% long-term target and the 20% growth that you saw in the first quarter is certainly very, very good. If there was a gating factor in terms of demand or the ability to grow even beyond that, where would it lie? Would it be your customers' willingness to trial and have the capital to do these trials? Or is it on the Avery side in terms of your ability to manage that type of growth? Or is it in the supply chain? How should we think about that if you - if there is, in fact, growth beyond the current range?

Yes. So we think the 15% to 20% is the right range overall, George, as we've reiterated. And as far as the gating factor, if you look at within apparel, it's not our ability to roll this out or anything. It's just there's a normal adoption curve as you go through these things. And we're always - when you actually go to first adoption for a particular retailer or brand, there's a big surge for that individual retail brand, creating tougher comps for the next level of rollout, so forth and so on. So we think that's the right target overall for the business. That's on apparel. If you look outside of apparel, I mean, it's very nascent, but we see a huge amount of opportunity there and a lot of pilots going on. And it's where apparel was 5, 6 years ago. We expect the lead time between much greater adoption and being at the pilot phase to be shorter than what it was in apparel. But that's essentially where it is. So very different whether you look at apparel, which is the primary driver of growth in dollars right now and for the coming years, and the newer categories we talked through. The only other thing I'll say is the pipeline has been up quite significantly within apparel even. So that was an accelerant. What happened with COVID was an accelerant within the apparel category, specifically, over the last from where we were 12 months ago. And we expect that we'll continue to see momentum and rollouts from those customers that we're working with now.

That's very helpful. Second part of the question, and then I'll throw my other one. I thought I heard you say that within RBIS, you had some benefit from releasing reserves on receivables. If I heard that correctly, could you quantify that? Or if I didn't catch that correctly, just state what you were getting at there. And then if you could talk about the other costs. I think you said the majority of the other temporary cost savings have come back into the P&L, but there's still some amount related to travel that hasn't come in, recognizing that's not going to come in until the businesses actually can sustain that, right, because you're required to travel and so on for commercial purposes. How would those numbers - how would you parse that? What's come in? What has yet to come in from the temporary cost saves?

All right. Thanks, George. Just on your first question, this is really about in the first quarter of last year, if you recall, at the start of the pandemic when really retail apparel started to get impacted heavily in the month of March, we saw some delays in payments and some things happening in the market there where we took more receivables reserves. We since worked through that through most of last year. So it wasn't really an item in Q1 of this year. It's really just more about the comparison to prior year, where we had a headwind last year in the first quarter that didn't repeat this year. And then on the temporary cost piece, as we talked about earlier, last year, we had about $135 million of temporary cost savings, and that was split into a few buckets. One was really volume-related items. And that was more about half of the overall savings. That's items like temporary cost reduction, overtime reduction, some furloughs, et cetera. And the majority of that, by the way, was really in Q2 of last year when we had the volume trough. And then another portion of that was incentive compensation, and the remainder was belt-tightening costs such as travel and other type of expenses like that. So the volume piece has clearly come back as we saw volume return late last year and into the first quarter as well as the incentive compensation pieces coming back here in the first quarter of 2021 as well. So it's really that last piece around more discretionary type of spend, belt-tightening type of spend that we would expect some of that to have come back already in Q1 and the rest to come back as we move through the year and people start traveling more and things like that. So we still would expect the majority of those savings to be a headwind this year versus what it was a year ago. And that would reduce a little bit - particularly in Q2, where we had the bulk of that savings last year, that would reduce a little bit of the flow-through from the incremental growth year-over-year as well.

Mr. Butier, I will now turn the call back to you for any closing remarks. Thank you.

Okay. Well, thank you, everybody, for joining. And once again, I just want to send a huge thanks to the entire team for their tremendous agility and just continued commitment to excellence. Thank you very much.

Thank you. And that, ladies and gentlemen, concludes the conference call for today. We thank you all for your participation and ask that you please disconnect your line. Thank you once again.